Clinicians discuss the rapidly evolving therapies, technology, and surgical approaches for early-stage NSCLC and take a fresh look at the future of care. Teamwork: A Multidisciplinary Approach to ...

Anna Wexler explains “do-it-yourself medicine” and how regulators can protect consumers using at-home medical therapies. Wexler contextualizes the emergence of the DIY medicine movement. She describes ...

Welcome to the UAB Internal Medicine Residency Program at the Huntsville Regional Medical Campus. We are committed to preparing our residents to successfully pursue any desired post-training career ...

Are there therapies to slow the decline in lung function that occurs in patients with bronchiectasis? Bronchiectasis is a progressive disease, and frequent exacerbations are critical events ...

The "best" cough medicine is ultimately based on the type of cough you have, as well as an evaluation of possible side effects. The three main types of over-the-counter (OTC) medicines adults can use ...

Apr. 22, 2025 — A multi-state study reveals that many high-risk adults diagnosed with influenza (flu) in emergency departments and urgent care centers are not receiving timely antiviral ...

The Uniformed Services Family Health Plan (USFHP) is a managed care program developed by the Department of Defense (DoD). Johns Hopkins USFHP is backed by Johns Hopkins Medicine (JHM), boasting over ...

These challenges with drug targeting drive up research and development costs – often exceeding $1-2 billion and over a decade of work per successful new medicine 3 – and leave patients without ...

The Faculty of Medicine is delighted to offer two types of scholarships for students starting full-time or part-time Master’s programmes in the upcoming academic year of study. Applications are ...

Advertisement A big dose of their own medicine is long overdue, highlighting every dangerous aspect of their policies and turning everyone against them by any means necessary. They have turned ...

“Older patients do just as well, sometimes better than younger patients with immunotherapy treatments,” says senior author Daniel Zabransky, M.D., Ph.D., an assistant professor of oncology at the ...